StressGen files for follow-on

StressGen (TSE:SSB) filed to sell 6 million shares in a follow-on underwritten by BMO Nesbitt Burns; CIBC World Markets; and Goepel McDermid. SSB, a developer of stress protein-based immunotherapeutic...